Introduction {#s1}
============

As the sister group of animals ([Figure 1A](#fig1){ref-type="fig"}), choanoflagellates have great potential for revealing the origins of animal development and the cell biology of multicellularity ([@bib60]; [@bib16]; [@bib17]; [@bib89]; [@bib38]). Comparative genomic studies have demonstrated that choanoflagellates express genes that are necessary for animal development ([@bib57]; [@bib30]; [@bib87]; [@bib70]), including genes for intercellular adhesion (e.g. cadherins: [@bib1]; [@bib77]), signaling (e.g. receptor tyrosine kinases and CamKII: [@bib72]; [@bib84]; [@bib10]; [@bib5]), and cellular differentiation (e.g. myc, STAT, and p53: [@bib111]; [@bib25]). Moreover, choanoflagellates and animals are the only clades that have cells with a collar complex ([@bib63]; [@bib15]), a unique cellular module in which a collar (*choano* in Greek) of actin-filled microvilli surrounds an apical flagellum ([Figure 1B](#fig1){ref-type="fig"}; [@bib92]; [@bib82]; [@bib21]). Together, these observations have motivated the development of choanoflagellates as models for researching the function and evolution of core developmental regulators ([@bib56]; [@bib42]; [@bib93]; [@bib15]).

![Introduction to *Salpingoeca rosetta* as a simple model for multicellularity and the ancestry of animal cell biology.\
(**A**) Choanoflagellates (blue) are the closest living relatives of animals (red) and last shared a common ancestor (purple) \~800 million years ago ([@bib81]). (**B**) The collar complex, an apical flagellum (f) surrounded by a collar (c) of actin-filled microvilli, typifies choanoflagellates and is uniquely shared between choanoflagellates and animals ([@bib15]). (**C**) Wild-type *S. rosetta* forms multicellular rosette colonies in response to rosette inducing factors (RIFs) secreted by environmental bacteria. In the absence of RIFs (**C'**), *S. rosetta* grows as single cells or as a linear chain of cells (star). Upon the addition of RIFs (C'; [@bib3]; [@bib105]), *S. rosetta* develops into spheroidal, multicellular rosettes (arrowhead) through serial cell divisions ([@bib29]). (**D**) The *rosetteless* C-type lectin gene is necessary for rosette development. A mutation in *rosetteless* allows normal cell growth as single cells and linear chains in the absence of RIFs (**D'**) but prevents rosette development in the presence of RIFs (D'; [@bib64]). (**E**) Wild-type *S. rosetta* secretes Rosetteless protein from the basal ends of cells into the interior of rosettes. Shown is a representative rosette stained with an antibody to alpha-tubulin to mark cortical microtubules and the apical flagellum of each cell (E', grey) phalloidin to mark actin-filled microvilli (E', magenta), and an antibody to Rosetteless protein (E''', green). A merge of alpha-tubulin, phalloidin, and Rosetteless staining shows that Rosetteless protein localizes to the interior of rosettes (arrow) where cells meet at their basal ends (E\'\'\'\'; [@bib64]).](elife-56193-fig1){#fig1}

The choanoflagellate *Salpingocea rosetta* has received the greatest investment in tool development ([@bib42]). Its 55.44 megabase genome encodes \~11,629 genes, some of which are homologs of integral regulators for animal development ([@bib30]). Moreover, the life history of *S. rosetta* provides a rich biological context for investigating the functions of intriguing genes ([@bib55]; [@bib29]; [@bib24]; [@bib65]; [@bib106]). For example, *S. rosetta* develops into multicellular, spheroidal colonies called rosettes through serial cell divisions from a single founding cell ([@bib29]; [@bib62]; [@bib61]), a process induced by environmental bacteria that can also serve as a food source ([Figure 1C](#fig1){ref-type="fig"}; [@bib3]; [@bib105]). Thus, rosette development can provide a phylogenetically relevant model for discovering genes that mediate multicellular development and bacterial recognition in choanoflagellates and animals.

A forward genetic screen was established to hunt for mutants that were unable to develop into rosettes and resulted in the identification of genes required for rosette development ([@bib64]; [@bib104]). The first of these ([@bib64]), *rosetteless* encodes a C-type lectin protein that localizes to the interior of rosettes ([Figure 1D--E](#fig1){ref-type="fig"}). As C-type lectins are important for mediating intercellular adhesion in animals ([@bib28]; [@bib23]), this discovery highlighted the conserved role of an adhesion protein family for animal and choanoflagellate development. However, the screen also underscored the necessity for targeted genetics in *S. rosetta*. Because of inefficient mutagenesis in *S. rosetta*, forward genetics has been laborious: out of 37,269 clones screened, only 16 rosette-defect mutants were isolated and only three of these have been mapped to genes ([@bib64]; [@bib104]). Establishing genome editing would accelerate direct testing of gene candidates identified through forward genetic screens, differential gene expression, and/or genomic comparisons.

Therefore, for the present study, we sought to establish CRISPR/Cas9 genome editing in *S. rosetta*. Cas9-mediated genome editing ([@bib47]; [@bib48]; [@bib22]) has been crucial for advancing genetics in emerging models ([@bib36]; [@bib41]; [@bib75]). Depending on the DNA repair pathways expressed in a given organism ([@bib110]), the delivery of the Cas9 endonuclease bound to a programmable guide RNA (gRNA) can direct DNA cleavage at a target site to introduce mutations from co-delivered DNA templates or from untemplated repair errors that cause insertions or deletions ([@bib88]; [@bib20]; [@bib11]; [@bib48]; [@bib22]). While the delivery of macromolecules into choanoflagellate cells has been a longstanding barrier for establishing reverse genetic tools, we recently established a robust method to transfect *S. rosetta* with DNA plasmids for expressing transgenes ([@bib12]), which allowed us to perform genetic complementation ([@bib104]). Despite having established a method for gene delivery in *S. rosetta*, the lack of knowledge about DNA repair mechanisms in choanoflagellates and low-transfection efficiency (\~1%) presented challenges for establishing genome editing, particularly without a proven selectable marker in an endogenous gene to enrich for editing events.

Here we report a reliable method for genome editing to perform reverse genetics in *S. rosetta* that we have developed into a publicly-accessible protocol (<https://dx.doi.org/10.17504/protocols.io.89fhz3n>). First, we engineered a selectable marker for cycloheximide resistance as an initial demonstration of genome editing with CRISPR/Cas9 ([Figure 2](#fig2){ref-type="fig"}). We then inserted a foreign sequence into *rosetteless* that eliminates its function, confirming the importance of this gene for multicellular rosette development ([Figure 3](#fig3){ref-type="fig"}). Finally, we found that, even in the absence of selection, *S. rosetta* preferentially uses DNA templates to introduce mutations for genome editing ([Figure 4](#fig4){ref-type="fig"}). This work establishes genome editing in *S. rosetta* and provides a path for testing the function of choanoflagellate genes that are implicated in the early evolution of animals.

![Engineered cycloheximide resistance in *S. rosetta* provides a proof-of-principle for Cas9-mediated genome editing.\
(**A**) Schematic of Cas9-mediated genome editing to engineer cycloheximide resistance in *S. rosetta*. Nucleofection was used to deliver *Sp*Cas9 (gray) bound to gRNA (cyan), which together form the *Sp*Cas9 RNP, and repair oligonucleotides (Repair Oligo; [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) to engineer cycloheximide resistance. After recovering cells for one day, successfully edited cells were selected by growth in media supplemented with cycloheximide (cyh), which inhibits the growth of wild-type cells ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and selects for cycloheximide-resistant cells (purple). (**B**) A designer cycloheximide-resistant allele ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) allows cell proliferation in the presence of cycloheximide. Wild-type (WT, black dots and line) and *rpl36a^P56Q^* (purple dots and line) strains were placed into media supplemented with a range of cycloheximide concentrations (x-axis) at a cell density of 10^4^ cells/ml and then were grown for two days. *rpl36a^P56Q^* grew to higher cell densities than the wild-type strain at cycloheximide concentrations \< 10 ng/ml. At higher concentrations, cycloheximide inhibited growth of both strains. The dots show cell densities from three independent replicates. The lines show the average from independently fitting a dose inhibition curve to the cell densities from three independent experiments.](elife-56193-fig2){#fig2}

![Genome editing of *rosetteless* enables targeted disruption of multicellular development in *S. rosetta.*\
(**A**) An engineered mutation in *rosetteless* introduces a premature termination sequence (PTS) to knockout the expression of *rosetteless*. The *rosetteless* gene (exons shown as numbered black boxes, connected by introns) encodes a secreted protein (SS denotes the signal sequence for secretion) with two C-type lectin domains (CTL1 and CTL2) and two carboxy-terminal repeats (RP1 and RP2). A forward genetic screen ([@bib64]) identified a mutation, *rtls^tl1^*, in which a T to C transition in the seventh intron disrupts splicing and knocks out *rosetteless* expression. To increase the likelihood of disrupting *rosetteless* function with genome editing, we designed the *rtls^PTS1^* mutation that introduces a PTS (green), with a poly-adenylation sequence and stop codons in each reading frame, into the fourth exon of the gene. (**B**) The genotypes of strains established from genome-editing confirm that *rosetteless* and *rpl36a* incorporated the designed mutations. To enrich for genome-edited cells, *Sp*Cas9 RNPs and repair templates for introducing *rpl36a^P56Q^* ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) and *rtls^PTS1^* were simultaneously delivered into *S. rosetta*. Afterward, cycloheximide resistant cells were clonally isolated and screened for cells that did not develop into rosettes in the presence of RIFs. The genotypes of *rtls^PTS1^ rpl36a^P56Q^*, and *rpl36^P56Q^* confirmed that strains established from genome editing had the *rpl36^P56Q^* allele and the strain with the *rosetteless* phenotype also had the *rtls^PTS1^* allele. In addition, the wild-type and genome edited strains lacked the T to C transition in the 5'-splice site of intron seven that defined the *rtls^tl1^* allele. (**C--F**) Phenotypes of genome-edited strains correspond to their respective genotypes. In the absence of RIFs, all strains (C', D', E', and F') grew as chains (stars) or single cells. Upon the addition of RIFs, the wild-type (**C"**) and *rpl36^P56Q^* strains (**D"**) formed rosettes (arrowheads). In contrast, *rtls^PTS1^ rpl36^P56Q^* (**E"**) and *rtls^tl1^* (**F"**) did not form rosettes. (**G--J**) Mutations in *rosetteless* prevent the secretion of Rosetteless protein at the basal end of cells and into the interior or rosettes. Immunofluorescent staining for Rosetteless (green), alpha tubulin (gray), and actin (magenta) in wild-type (**G**), *rpl36a^P56Q^* (**H**), *rtls^PTS1^ rpl36a^P56Q^* (**I**), and *rtls^tl1^* (**J**) strains with (**G"--J"**) and without (**G'--J'**) rosette induction. Rosetteless localizes in the interior of rosettes (arrow) in wild-type and *rpl36a^P56Q^* but not *rtls^PTS1^ rpl36a^P56Q^* and *rtls^tl1^*.](elife-56193-fig3){#fig3}

![*S. rosetta* preferentially introduces genome-edited mutations from DNA templates.\
(**A**) Schematic of a gRNA targeting *Sp*Cas9 to a genomic locus of interest. A gRNA (cyan, knobs indicate 5' ends) that encodes a 20 nt targeting sequence from the sense strand of a genomic locus (black) hybridizes with the antisense strand (dark gray). *Sp*Cas9 (light gray) introduces a double-stranded break at the genomic locus (carets), 3 bp upstream of a protospacer adjacent motif (PAM, orange). (**B**) We designed a panel of repair oligonucleotides to test the preferred substrates for repairing double-stranded breaks introduced by *Sp*Cas9 at *rosetteles* exon 4. Oligonucleotide repair templates containing the PTS sequence (green) were delivered as single-stranded DNA in the sense (**S**) or anti-sense (**A**) orientations and as a double-stranded template (**D**) to test which most efficiently templated DNA repair at the *Sp*Cas9 cleavage site. (**C**) *Sp*Cas9 stimulated the introduction of PTS mutations from DNA templates. Repair templates with a PTS (from panel B) were delivered in the presence and absence of *Sp*Cas9 (+/--). A \~ 450 bp fragment surrounding the *rtls^PTS1^* cleavage site was amplified from cells that had been transfected the previous day to prepare deep sequencing libraries for quantifying the frequency of PTS insertions (green) or insertions/deletions from error prone editing (black). Each experiment was performed three independent times (dots; mean and standard deviations are shown with lines). The dotted line indicates the limit of detection of the sequencing, based on a 6-base, randomized barcode. Upon transfection with the *Sp*Cas9 RNP, 10x more mutations from repair templates (1--2%, green dots) were detected than untemplated insertions or deletions (black dots). In the absence of *Sp*Cas9, mutations generated from a double-stranded template, but not single-stranded templates, were rarely (\<0.1%) and unreliably (2 of 3 trials) found.](elife-56193-fig4){#fig4}

Results {#s2}
=======

A marker to select for cycloheximide resistance facilitates genome editing in *S. rosetta* {#s2-1}
------------------------------------------------------------------------------------------

Our initial attempts to target rosetteless for genome editing in *S. rosetta* were either unsuccessful or resulted in editing events that were below the limits of detection. Therefore, suspecting that genome editing in *S. rosetta* might prove to be challenging to establish, we first aimed to introduce a mutation in an endogenous gene that would confer antibiotic resistance and allow selection for rare genome editing events.

In *Chlamydomonas* ([@bib98]) and Fungi ([@bib51]; [@bib26]; [@bib59]; [@bib52]), specific mutations in the ribosomal protein gene *rpl36a* confer resistance to the antibiotic cycloheximide by disrupting cycloheximide binding to the large subunit of eukaryotic ribosomes ([@bib99]; [@bib91]; [@bib34]). After finding that *S. rosetta* cell proliferation was inhibited by cycloheximide ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), we sought to establish a cycloheximide-resistant strain through genome editing. By combining prior genetic findings ([@bib9]) with our own structural modeling ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) and bioinformatic analyses ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}) of the *S. rosetta rpl36a* homolog (PTSG_02763), we predicted that converting the 56^th^ codon of *rpl36a* from a proline to a glutamine codon (*rpl36a^P56Q^*) would render *S. rosetta* resistant to cycloheximide ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). Insertion or deletion mutations that could arise as errors from repairing the double-stranded break without a template would likely kill cells by disrupting the essential function of *rpl36a* for protein synthesis ([@bib9]).

To edit the *rpl36a* gene in *S. rosetta*, we first designed a gRNA with a 20 nt sequence from *rpl36a* to direct Cas9 from *Streptomyces pyogenes* (*Sp*Cas9) to cut at *S. rosetta* supercontig 6: 948,122 nt ([@bib30]). Then we made a DNA repair template as a single-stranded DNA oligonucleotide with a sequence encoding the Pro56Gln mutation and 200 bases of flanking homologous sequence from *rpl36a* centered on the cleavage site ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). To deliver the *Sp*Cas9/gRNA ribonucleoprotein complex (*Sp*Cas9 RNP) and the repair template encoding the Pro56Gln mutation into *S. rosetta* cells, we used a nucleofection protocol adapted from our recently developed method for transfecting *S. rosetta* ([Figure 2A](#fig2){ref-type="fig"}; [@bib12]). We favored delivering the *Sp*Cas9 RNP rather than expressing *Sp*Cas9 and gRNAs from plasmids, as RNA polymerase III promoters for driving gRNA expression have not yet been characterized in *S. rosetta* and the overexpression of *Sp*Cas9 from plasmids can be cytotoxic for other organisms ([@bib44]; [@bib45]; [@bib94]; [@bib32]) as well as increase the likelihood of introducing off-target mutations ([@bib54]; [@bib67]; [@bib40]). After growing transfected cells in the presence of cycloheximide for five days, Sanger sequencing of PCR-amplified *rpl36a* showed that *rpl36a^P56Q^* was the major allele in the population ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, compare B and C). Sequencing a clonal strain established from this population confirmed the *rpl36a^P56Q^* genotype ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}), and growth assays showed that the *rpl36a^P56Q^* strain proliferated better than the wild-type strain in increasing concentrations of cycloheximide ([Figure 2B](#fig2){ref-type="fig"}; Two-Factor ANOVA: p\<10^−20^).

The ability to engineer cycloheximide resistance additionally offered a simple assay to optimize essential parameters for genome editing in *S. rosetta*. Therefore, we tested how varying delivery conditions would impact the frequency of template-mediated mutagenesis and, ultimately, the cell density and consensus genotype of a cell population after genome editing and cycloheximide treatment ([Figure 2---figure supplement 2E--H](#fig2s2){ref-type="fig"}). Through this optimization process ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), we found that efficient genome editing required transfection with at least 20 pmol of *Sp*Cas9 RNP and more than 200 nmol of a single-stranded DNA repair template that had 50 bases of homology flanking a designed mutation. Henceforth, these parameters established baseline conditions for designing and executing genome editing experiments.

Targeted disruption of rosetteless demonstrates its essentiality for multicellular rosette development {#s2-2}
------------------------------------------------------------------------------------------------------

We next sought to use genome editing as a general tool for reverse genetics in choanoflagellates. To this end, we targeted *rosetteless* (*rtls*), one of only three genes known to be required for rosette development in *S. rosetta* ([@bib64]; [@bib104]). A prior forward genetic screen linked the first rosette defect mutant to an allele, *rtls^tl1^*, in which a T to C transition in the 5'-splice site of intron 7 (*S. rosetta* supercontig 8: 427,804 nt; [@bib30]) was associated with the disruption of *rtls* expression and rosette development ([Figures 3A](#fig3){ref-type="fig"} and [1C--E](#fig1){ref-type="fig"}; [@bib64]). We therefore sought to generate a new *rtls* knockout allele, whose phenotype we predicted would be the loss of rosette development.

To increase the likelihood of generating a *rtls* knockout through genome editing, we aimed to introduce sequences that would prematurely terminate transcription and translation near the 5' end of the gene. First, we designed a gRNA that would target *Sp*Cas9 to the 5' end of *rtls*. Next, we designed a general-purpose premature termination sequence (PTS), an 18-base, palindromic sequence (5'-TTTATTTAATTAAATAAA-3') that encodes polyadenylation sequences and stop codons on both strands and in each possible reading frame. This sequence should prematurely terminate transcription and translation to either create a gene truncation or fully knockout target gene expression. We then designed a DNA oligonucleotide repair template in which the PTS was inserted into 100 bp of *rtls* sequence centered around the *Sp*Cas9 cleavage site (supercontig 8: 429,354 nt).

The low efficiency of transfection (\~1%; [@bib12]), the inability to select for cells with the Rosetteless phenotype, and the unknown but potentially low efficiency of genome editing meant that it might be difficult to recover cells in which *rosetteless* had been edited. To overcome this challenge, we sought to simultaneously edit *rosetteless* and *rpl36a* by transfecting cells with RNPs complexed with gRNAs and DNA repair templates for both knocking out *rosetteless* and engineering cycloheximide resistance. In other organisms, this approach has allowed for co-selection by using a selectable marker to improve the recovery of cells that contain a second mutation in a different locus. In *S. rosetta*, we found that 10.4--16.5% of cycloheximide resistant cells contained the *rtls^PTS1^* allele when *rosetteless* and *rpl36a* were co-edited ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}).

By first selecting for cycloheximide resistance and then performing clonal isolation by limiting dilution, we were able to isolate multiple clonal lines that were resistant to cycloheximide. We focused on one strain that correctly formed rosettes in response to bacterial rosette inducing factors (RIFs; [Figure 3D](#fig3){ref-type="fig"}; [@bib3]; [@bib105]) and two cycloheximide-resistant strains that failed to form rosettes in the presence of RIFs (representative strain shown in [Figure 3E](#fig3){ref-type="fig"}). Genotyping of these strains at exon 4 of *rosetteless* and at *rpl36a* ([Figure 3B](#fig3){ref-type="fig"}) showed that: (1) all three cycloheximide resistant strains established from the same genome-edited population had the cycloheximide resistance allele, (2) the strains that developed into rosettes only had the cycloheximide resistant allele, *rpl36a^P56Q^*, and (3) the two strains that did not develop into rosettes also had the PTS in *rosetteless* exon 4, meaning their genotype was *rtls^PTS1^ rpl36a^P56Q^* ([Figure 3B](#fig3){ref-type="fig"}). For comparison, we also genotyped wild-type, *rpl36a^P56Q^*, *rtls^PTS1^ rpl36a^P56Q^*, and *rtls^tl1^* strains at intron 7 of *rosetteless*, where the *rtls^tl1^* mutation was mapped, to underscore that *rtls^PTS1^* is an independent mutation that prevents the development of rosettes ([Figure 3B](#fig3){ref-type="fig"}).

To further validate the genotype-to-phenotype relationship of the *rosetteless* knockouts ([Figure 3C--F](#fig3){ref-type="fig"}), we analyzed the percentage of cells that developed into rosettes ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), the localization of the Rosetteless protein ([Figure 3G-J](#fig3){ref-type="fig"}), and the rates of proliferation ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) in the wild-type, *rpl36a^P56Q^*, *rtls^PTS1^ rpl36a^P56Q^*, and *rtls^tl1^* strains of *S. rosetta*. In each of these assays, the *rtls^PTS1^ rpl36a^P56Q^* strains exhibited the same phenotype as *rtls^tl1^* ([Figure 3](#fig3){ref-type="fig"}, compare E to F): no cells developed into rosettes ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), an anti-Rosetteless antibody did not detect Rosetteless protein at the basal end of cells ([Figure 3](#fig3){ref-type="fig"}, compare I-J to G), and the mutant and wild-type strains proliferated comparably well ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Furthermore, *rpl36a^P56Q^* developed into wild-type rosettes ([Figure 3](#fig3){ref-type="fig"}, compare D to C and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) localized Rosetteless protein to the basal end of cells ([Figure 3](#fig3){ref-type="fig"}, compare H to G), and proliferated as rapidly as the wild-type strain ([Figure 3---figure supplement 2A--B,E](#fig3s2){ref-type="fig"}), demonstrating that the act of genome editing alone does not yield non-specific defects in rosette development. Our ability to engineer a new *rosetteless* allele, *rtls^PTS1^,* that mimics the rosette-defect phenotype of *rtls^tl1^* demonstrates the potential of genome editing as a general tool for generating targeted gene knockouts in choanoflagellates.

*S. rosetta* preferentially introduces genome-edited mutations from DNA templates {#s2-3}
---------------------------------------------------------------------------------

Thus far, we had only detected mutations from repair templates with homology arms spanning both sides of the double-strand break ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). However, selecting for cycloheximide resistance may have favored those repair outcomes, as insertion or deletion (INDEL) mutations arising from untemplated repair are likely to be deleterious for the function of *rpl36a*. Therefore, to investigate the frequency of template-mediated repair in the absence of selection, we sought to edit *rosetteless*, which is not required for viability ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).

As prior work has shown that editing outcomes in different cell types ([@bib41]; [@bib110]) can depend on the length and orientation (anti-sense or sense) of homology arms ([@bib68]; [@bib49]; [@bib86]; [@bib80]; [@bib66]; [@bib79]) and chemical modifications of DNA repair templates ([@bib102]; [@bib85]; [@bib112]), we designed a panel of diverse double- and single-stranded DNA repair templates that all contained the PTS ([Figure 4B](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The double-stranded templates contained phosphorylation or phosphorothioate bonds at their 5' ends ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}); whereas, the single-stranded templates varied in their orientation and presence of 5' or 3' homology arms ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). We transfected cells with these repair templates with or without the *Sp*Cas9 RNP. After the cells recovered for one day, we amplified a \~ 450 bp fragment around the *Sp*Cas9 cut site for deep sequencing ([@bib109]; [@bib68]) and quantified the frequency and type of mutation after genome editing.

We found that the *S. rosetta* genome could be edited in a *Sp*Cas9-dependent manner using a variety of templates ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). In the presence of the *Sp*Cas9, INDEL mutations occurred at a frequency of \<0.1%, either in the presence or absence of DNA repair templates ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1D--E](#fig4s1){ref-type="fig"}). In contrast, the addition of *Sp*Cas9 with DNA repair templates that encoded the PTS resulted in PTS mutations at a frequency of 0.79--1.57%, which is at a ten-fold higher frequency than the INDEL mutational frequency (Two-Factor ANOVA: p\<10^−13^). Notably, the total frequency of genome editing (\~1%) is on the same order of magnitude as transfection efficiency (\~1%; [@bib12]), suggesting that the delivery of *Sp*Cas9 and repair templates is the biggest factor limiting genome editing efficiency.

In the absence of *Sp*Cas9, we observed two types of *Sp*Cas9-independent genome edits. The first was a single INDEL mutation detected in a population of cells transfected with the antisense repair template, and the second was the detection of PTS mutations at an average frequency of \~0.02% upon the delivery of a double-stranded repair template. Although the frequency of these mutations occurred at a rate less than or equal to the detection threshold (\~0.02%), meaning that we could not confidently conclude that differences exist between any of the samples (Two-Factor, ANOVA: p\<0.27), the presence of these mutations is consistent with a low frequency of endogenous DNA repair. These results also emphasize that the addition of *Sp*Cas9 was essential for efficient, targeted mutagenesis (Two-Factor ANOVA: p\<0.02 for INDEL mutations and p\<10^−13^ for PTS mutations).

Altogether, our optimization efforts revealed that the delivery of the *Sp*Cas9 with a DNA template spanning both sides of the *Sp*Cas9 cleavage site introduced PTS mutations at a frequency of \~1%. We recommend using a sense-oriented, single-stranded template for genome editing, as this template led to the highest frequency of PTS mutations (Single-Factor ANOVA, Tukey Multiple Comparison Test: p\<*0.04*) and costs less to synthesize than a double-stranded template.

Discussion {#s3}
==========

The establishment of Cas9-mediated genome editing advances *S. rosetta* as a model for illuminating the evolution of development in choanoflagellates and their closest living relatives, animals. We were able to overcome initial failed efforts to establish genome editing in *S. rosetta* by engineering cycloheximide resistance in *rpl36a* as a selectable marker, similar to the use of selectable markers during the establishment of genome editing in other eukaryotes, including Fungi ([@bib32]), green algae ([@bib31]), and nematodes ([@bib7]; [@bib53]; [@bib103]). Single-copy ribosomal protein genes like *rpl36a* offer certain advantages for engineering drug resistance markers with genome editing. First, resistance mutations in ribosomal protein genes have been genetically and biochemically characterized for a variety of drugs in diverse eukaryotes ([@bib100]; [@bib6]; [@bib51]; [@bib26]; [@bib59]; [@bib52]; [@bib98]; [@bib34] and references therein). In our case, interpreting alignments among Rpl36a sequences from *S. rosetta* and organisms in the context of structures of eukaryotic ribosomes provided a starting point for customizing cycloheximide resistant alleles, a strategy that can also extend to other organisms. Second, the specificity of antibiotics that inhibit eukaryotic or prokaryotic translation can be leveraged to tailor genetic tools for particular organisms in complex communities. For example, cycloheximide binds selectively to eukaryotic ribosomes, resulting in the inhibition of *S. rosetta* growth and not that of its food source: live prey bacteria. Combining these advantages to establish genome editing in *S. rosetta* provided the first proof-of-principle for genome editing and allowed us to characterize the essential parameters before targeting other genes.

With the newfound potential for reverse genetics, we revisited the genetic basis of multicellular rosette development in *S. rosetta*. A previous forward genetic screen followed by mapping crosses implicated the C-type lectin gene *rosetteless* in the regulation of rosette development ([@bib64]). At the time, however, it was not possible to independently corroborate *rosetteless* function with targeted mutations. In this study, we used genome editing to introduce a premature termination sequence in *rosetteless* and found that strains with the engineered *rosetteless* mutation have the same rosette defect phenotype as cells with the original *rtls^tl1^* mutation, demonstrating that *rosetteless* is necessary for rosette development.

Moving forward, the approach established here promises to accelerate future research on choanoflagellates. It will now be possible for choanoflagellate researchers to introduce candidate mutations into a wild-type strain or correct the causative mutations in the original mutant strain to cleanly test the connection between genotype and phenotype. Similarly, for reverse genetics, the use of different guide RNAs and repair templates through CRISPR/*Sp*Cas9 genome editing will allow researchers to engineer multiple independent alleles to better understand the phenotype of targeted gene knockouts. Tools that have been previously used in forward genetic approaches, such as genetic crosses ([@bib65]; [@bib64]; [@bib106]) and stable transgenesis ([@bib104]), may also provide the means to rapidly generate strains with different genetic backgrounds to complement mutants, to reveal epistasis, or simply to eliminate off-target mutations that may arise during genome editing.

Importantly, the establishment of genome editing in *S. rosetta* offers the first model choanoflagellate to investigate the ancestral and core functions of genes that evolved as integral regulators of animal biology. The *S. rosetta* genome ([@bib30]) encodes receptors for immunity (e.g. Toll-like receptors), intercellular communication (e.g. receptor tyrosine kinases), and adhesion (e.g. cadherins, C-type lectins, and immunoglobulins) as well as master regulators of cell differentiation (e.g. forkhead, homeodomain, p53 and sox transcription factors). As a simple microbial model, *S. rosetta* now may serve as an accessible system for uncovering the conserved functions of genes that are not as readily studied in the more complex context of multicellular animals. Moreover, *S. rosetta* is just one tip on the choanoflagellate branch. Recent surveys of 21 choanoflagellate transcriptomes and genomes from uncultured species have revealed that choanoflagellates are at least as genetically diverse as animals ([@bib87]; [@bib70]), with other species retaining genetic pathways or exhibiting behaviors that are not found in *S. rosetta* (e.g., [@bib73]; [@bib63]; [@bib14]). Together with future findings from *S. rosetta*, we anticipate that the establishment of genome editing in other choanoflagellates will provide an increasingly complete portrait of the last common ancestor of choanoflagellates and animals.

Materials and methods {#s4}
=====================

Culturing choanoflagellates {#s4-1}
---------------------------

Strains of *S. rosetta* were co-cultured with *Echinicola pacifica* bacteria ([@bib65]); American Type Culture Collection \[ATCC\], Manassas, VA; Cat. No. PRA-390) in seawater-based media enriched with glycerol, yeast extract, and peptone to promote the growth of *E. pacifica* that serve as the choanoflagellate prey ([@bib65]; [@bib12]). We further supplemented this media with cereal grass ([@bib58]; [@bib29]; Carolina Biological Supply Company, Burlington, NC; Cat. No. 132375), which we call high nutrient media ([Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table A), as we noticed that this addition promoted *S. rosetta* growth to a higher cell density (\~10^7^ cells/ml \[[Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}\] versus \~10^6^ cells/ml ([@bib12]). To maintain rapidly proliferating cells in an abundance of nutrients, cultures were diluted 1 in 30 daily or 1 in 60 every two days into 6 ml of high nutrient media in 25 cm^2^ vented culture flasks (Corning, Oneonta, NY, USA; Cat. No. 430639) and incubated at 22°C and 60% relative humidity. To prevent an overgrowth of bacteria when *S. rosetta* experienced stress, such as after transfections or during clonal isolation, we cultured *S. rosetta* in low nutrient media, which is 0.375x high nutrient media ([Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table A).

Purification of outer membrane vesicles that contain RIFs {#s4-2}
---------------------------------------------------------

Rosette inducing factors (RIFs) contained in outer membrane vesicles (OMVs) from *Algoriphagus machipongonensis* ([@bib4]; ATCC; Cat. No. BAA-2233) can be used to induce rosette development in *S. rosetta* ([@bib3]; [@bib105]). *A machipongonensis* OMVs were purified using the protocol in [@bib105]. In summary, a 200 ml culture of 25x high nutrient media without cereal grass was inoculated from a single colony of *A*. *machipongonensis* and grown in a 1 l, baffled flask by shaking at 200 rpm for 3 days at 30°C. Afterwards, the bacteria were pelleted in 50 ml conical tubes by centrifugation at 4500 g and 4°C for 30 min. The pellet was discarded and the supernatant was filtered through a 0.22 µm vacuum filter. Outer membrane vesicles were pelleted from the filtered supernatant by ultracentrifugation at 36,000 g and 4°C in a fixed-angle, Type 45 Ti rotor (Beckman Coulter Life Sciences, Indianapolis, IN; Cat. No. 339160) for 3 hr. After discarding the supernatant, the pellet of outer membrane vesicles, which has an orange hue, was resuspended in a minimal volume of 50 mM HEPES-KOH, pH 7.5 and then incubated at 4°C overnight to fully dissolve the pellet. Last, the pellet was sterile filtered through a 0.45 µm polyvinylidene fluoride syringe filter (Thermo Fisher Scientific, Waltham, MA; Cat. No. 09-720-4) into a sterile tube.

The rosette-inducing activity of the OMVs was tested by serially diluting the purified OMVs in a 24-well plate, with each well containing 0.5 ml of *S. rosetta* at a concentration of 10^4^ cells/ml and *E. pacifica*. The cells were incubated with OMVs at 22°C for 48 hr and then fixed with formaldehyde before counting the fraction of cells (*n* = 100) in rosettes. The dilution of lipids in which half of *S. rosetta* cells formed rosettes was defined as two unit/ml. All subsequent rosette inductions were performed with OMVs at a final concentration of 10 units/ml.

Genome editing {#s4-3}
--------------

Below we describe the considerations for the design and preparation of gRNAs and repair oligonucleotides for genome editing. The particular gRNAs and DNA repair template sequences for each given experiment are provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table B.

Design and preparation of gRNAs {#s4-4}
-------------------------------

Upon inspecting the structure of the *Sp*Cas9 RNP poised to cleave a DNA target ([@bib46]), we concluded that sequences adjacent to and upstream of the PAM sequence (5'-NGG-3'), which have been reported to bias *Sp*Cas9 activity in vivo ([@bib27]; [@bib107]; [@bib108]; [@bib76]; [@bib43]; [@bib69]; [@bib50]; [@bib33]), likely influence *Sp*Cas9 recognition by stabilizing the conformation of the DNA target for cleavage. Therefore, we accounted for biases in *Sp*Cas9 recognition by choosing gRNAs sequences that conformed, as much as possible, to the motif 5'-HNNGR[SGG]{.ul}H-3', in which the PAM is underlined, N stands for any base, R stands for purine, S stands for G or C, and H stands for any base except G. This motif was first used to search for suitable targets ([@bib83]) in cDNA sequences. We reasoned that initially searching for putative targets in cDNA sequences would ensure that gRNAs direct *Sp*Cas9 to cleave in protein coding regions of genes, and we later verified that putative gRNAs recognized genomic sequences instead of exon-exon junctions. Finally, we filtered out putative gRNA sequences with potential secondary sequences that can impede gRNA hybridization with DNA targets ([@bib101]) by evaluating their predicted secondary structures ([@bib71]) and keeping gRNAs with predicted folding free energies greater than −1.5 kcal/mol.

gRNAs were prepared by annealing synthetic CRISPR RNA (crRNA) with a synthetic trans-activating CRISPR RNA (tracrRNA). The synthetic crRNA contains the 20 nt sequence for gene targeting and an additional sequence to anneal to the tracrRNA that binds to *Sp*Cas9. Alternatively, we also performed genome editing ([Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2H](#fig2s2){ref-type="fig"}) with in vitro transcribed gRNAs (see below) that link the crRNA and tracrRNA into one continuous strand ([@bib47]; [@bib18]), but we found that genome editing with crRNA/tracrRNA was the most time- and cost-effective. To prepare a functional gRNA complex from synthetic RNAs, crRNA and tracrRNA (Integrated DNA Technologies \[IDT\], Coralville, IA, USA) were resuspended to a final concentration of 200 µM in duplex buffer (30 mM HEPES-KOH, pH 7.5; 100 mM potassium acetate; IDT, Cat. No. 11-01-03-01). Equal volumes of crRNA and tracrRNA stocks were mixed together, incubated at 95°C for 5 min in an aluminum heat block, and then the entire heat block was placed at room temperature to slowly cool the RNA to 25°C. The RNA was stored at −20°C.

In vitro transcription of gRNAs {#s4-5}
-------------------------------

DNA templates for in vitro transcription of gRNAs were amplified by PCR (Q5 DNA Polymerase; New England Biolabs \[NEB\], Ipswich, MA, USA, Cat. No. M0491L) from synthetic DNA templates (IDT; [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table B) that had a T7 promoter sequence appended to the 5' end of the guide sequence and a trans-activating CRISPR RNA (tracrRNA) sequence ([@bib18]) at the 3' end. The purified DNA templates (PCR cleanup kit; Qiagen, Venlo, NLD; Cat. No. 28006) were used to synthesize gRNAs with T7 RNA polymerase ([@bib74]) in reactions set up with these components: 40 mM Tris-HCl, pH 8.0; 2.5 mM spermidine; 0.01% (v/v) Triton X-100; 5 mM GTP; 5 mM UTP; 5 mM ATP; 5 mM CTP; 80 mg/ml PEG 8000; 32 mM magnesium chloride; 5 mM dithiothreitol; 10 ng/µl template DNA; 0.5 U/µl SUPERase•In (Thermo Fisher Scientific, Waltham, MA; Cat. No. AM2696); 2 U/µl T7 RNA polymerase (Thermo Fisher Scientific, Cat. No. EP0113); 0.025 mg/ml pyrophosphatase (Thermo Fisher Scientific, Cat. No. EF0221). After incubating the transcription reaction at 37°C for \>4 hr, the DNA template was digested with the addition of 0.1 U/µl TURBO DNase (Thermo Fisher Scientific, Cat. No. AM2239). After assessing the transcription products on denaturing, urea-polyacrylamide gel electrophoresis (PAGE), we found that the in vitro transcriptions yielded high amounts of gRNA with few byproducts. Therefore, we used a simplified protocol to purify gRNAs by first removing contaminating nucleotides with a desalting column (GE Healthcare Lifesciences, Pittsburgh, PA; Cat. No. 17085302) to exchange gRNA into 1 mM sodium citrate, pH 6.4. The gRNAs were then precipitated from the solution by adding 0.25 volumes of RNA precipitation buffer (1.2 M sodium acetate, pH 5.2; 4 mM EDTA-NaOH, pH 8.0; 0.04% sodium dodecyl sulfate \[SDS\]) and 2.5 volumes of ethanol. The precipitated RNA was centrifuged for 60 min at 4°C, washed once with 70% ethanol/water, and finally resuspended in 1 mM sodium citrate, pH 6.4.

After determining the concentration of gRNA, which has a 260 nm extinction coefficient of 1.41 × 10^6^ M^−1^cm^−1^, by UV-vis spectroscopy, the gRNA was diluted to a final concentration of 50 µM with 1 mM sodium citrate, pH 6.4. To ensure that the gRNA was properly folded, the gRNA was placed at 95°C for 5 min in an aluminum heat block and then slowly cooled to 25°C by placing the aluminum block on a room temperature bench top. Finally, gRNAs were stored at −20°C.

Design and preparation of repair oligonucleotides {#s4-6}
-------------------------------------------------

Repair oligonucleotides for generating knockouts were designed by copying the sequence 50 bases upstream and downstream of the *Sp*Cas9 cleavage site, which itself is 3 bp upstream of the PAM sequence (for example, 5'-N-cleave-NNN[NGG]{.ul}-3'; PAM sequence underlined). A PTS (5'-TTTATTTAATTAAATAAA-3') was inserted at the cleavage site. Importantly, this sequence has a stop codon (TAA) in each possible reading frame to terminate translate, a polyadenylation sequence (AATAAA) to terminate transcription, and a PacI sequence (5'-TTAATTAA-3') that can be used to genotype with restriction digests. Moreover, the knockout sequence is palindromic, so it can be inserted in the sense or antisense direction of a gene and still generate a knockout.

Dried oligonucleotides (IDT) were resuspended to a concentration of 250 µM in a buffer of 10 mM HEPES-KOH, pH 7.5, incubated at 55°C for 1 hr, and mixed well by pipetting up and down. The oligonucleotides were stored at −20°C.

SpCas9 expression and purification {#s4-7}
----------------------------------

For efficient genome editing, we purified or purchased (NEB, Cat. No. M0646M) an engineered version of *Streptomyces pyogenes* Cas9 that has SV40 nuclear localization sequences (NLS) at the amino- and carobxy- termini of *Sp*Cas9. Below we describe a simplified purification procedure based on the previously published work ([@bib47]).

### Vector construction {#s4-7-1}

Using a variation of Gibson cloning ([@bib35]; NEB, Cat. No. E2621L), we modified a vector ([@bib47]); Addgene, Watertown, MA; Cat. No. 69090) for expressing *Sp*Cas9 in *Escherichia coli* by inserting tandem SV40 NLSs at the amino terminus of *Sp*Cas9. A similar construct (Addgene, Cat. No. 88916) has been shown to increase nuclear localization in mammalian cells ([@bib22]; [@bib97]). The expression vector has a hexahistidine (His~6~) tag and maltose binding protein (MBP) fused to the amino terminus of *Sp*Cas9. A tobacco etch virus (TEV) protease cleavage site between MBP and the amino terminal nuclear localization sequence on Cas9 facilitates the removal of the His~6~-MBP tag from *Sp*Cas9.

### Protein expression {#s4-7-2}

The *Sp*Cas9 expression vector was transformed into the BL21 Star (DE3) strain of *E. coli* (Thermo Fisher Scientific, Cat. No. C601003), and a single colony of the transformants was inoculated into Miller's LB broth ([@bib8]) for growing a starter culture overnight at 37°C with shaking at 200 rpm. 20 ml of the starter culture was diluted into 1 L of M9 medium ([@bib8]) and the culture was grown at 37°C with shaking at 250 rpm until the OD~600~ = 0.60. At that cell density, the culture was shifted to 16°C for 15 min and *Sp*Cas9 expression was induced by addition isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. The culture was grown at 16°C overnight and cells were harvested by centrifugation at 4900 g and 4° for 15 min in a swinging bucket centrifuge. The supernatant was discarded and the bacterial pellets were flash frozen in liquid nitrogen and stored at −80°C.

### Protein purification {#s4-7-3}

The bacterial pellet was lysed by resuspending 1 g of bacterial pellet in 9 ml of lysis buffer (150 mM potassium phosphate, pH 7.5; 500 mM sodium chloride; 5 mM imidazole, pH 8.0; 1 mM Pefabloc SC; 2 mM 2-mercaptoethanol; 10% \[v/v\] glycerol; one protease inhibitor tablet \[cOmplete, EDTA-free; Roche; Cat. No, 04693132001\] per 20 ml of lysate) and lysing with a microfluidizer. The lysate was centrifuged at 30,000 g and 4°C for 30 min to remove insoluble debris.

The supernatant was passed through an Ni-NTA Agarose column (Qiagen, Cat. No. 30210) equilibrated in elution buffer (150 mM potassium phosphate, pH 7.5; 500 mM sodium chloride; 5 mM imidazole, pH 8.0; 2 mM 2-mercaptoethanol; 10% \[v/v\] glycerol), using 1 ml of resin per 10 grams of bacterial pellet. The column was washed with 10 column volumes (CV) of lysis buffer, 5 CV of elution buffer supplemented with 10 mM imidazole, and 3 CV of wash elution buffer supplemented with 20 mM imidazole. The protein was eluted from the column with 4 CV of elution buffer supplemented with 240 mM imidazole. After determining the protein concentration by UV-vis spectroscopy (using an extinction coefficient of 0.18829 µM^−1^cm^−1^ for *Sp*Cas9), TEV protease was added at 1:20 molar ratio of TEV protease to *Sp*Cas9. SpCas9 supplemented with TEV protease was placed in a dialysis bag with a 3500 dalton molecular weight cut-off (MWCO) and dialyzed against dialysis buffer (100 mM potassium phosphate, pH 7.5; 2 mM 2-mercaptoethanol; 10 mM imidazole; 10% \[v/v\] glycerol) overnight at 4°C. Afterwards, the dialyzed protein was passed over the Ni-NTA column that had been equilibrated in dialysis buffer to remove His~6~-MBP tag from *Sp*Cas9, which is in the flow through. The flow through was loaded onto HiTrap SP High-Performance (GE Healthcare Lifesciences, Cat. No. 17-1152-01) column that had been equilibrated in dialysis buffer. The column was extensively washed with dialysis buffer prior to eluting the protein in S-elution buffer (500 mM potassium phosphate, pH 7.5; 3 mM dithiothreitol; 0.3 mM EDTA-KOH, pH 8.0; 10% \[v/v\] glycerol). The purity was evaluated by SDS-PAGE, and the concentration was measured using UV-vis spectroscopy. Afterwards, the purified protein was concentrated with a 100,000 MWCO centrifugal filter to a final concentration of 20--25 µM. The concentrated protein was flash-frozen in liquid nitrogen and stored at −80°C.

Delivery of gene editing cargoes with nucleofection {#s4-8}
---------------------------------------------------

SpCas9 RNPs and DNA repair templates were delivered into *S. rosetta* using a modified method for nucleofection ([@bib12]). Here we describe the complete transfection procedure and provide a publicly-accessible protocol specific for genome editing (<https://dx.doi.org/10.17504/protocols.io.89fhz3n>):

### Cell culture {#s4-8-1}

Two days prior to transfection, 120 ml of high nutrient media was inoculated with a culture of *S. rosetta/E. pacifica* to a final concentration of *S. rosetta* at 8000 cells/ml. The culture was grown in a 3-layer flask (Corning; Cat. No. 353143), which has a surface area of 525 cm^2^, at 22°C and 60% humidity.

### Assembly of Cas9/gRNA RNP {#s4-8-2}

Before starting transfections, the *Sp*Cas9 RNP was assembled. For one reaction, 2 µl of 20 µM *Sp*Cas9 (NEB, Cat. No. M0646M or purified as described above) was placed in the bottom of a 0.25 ml PCR tube, and then 2 µl of 100 µM gRNA was slowly pipetted up and down with *Sp*Cas9 to gently mix the solutions. The mixed solution was incubated at room temperature for 1 hr, which is roughly the time to complete the preparation of *S. rosetta* for priming (see below).

### Thaw DNA oligonucleotides {#s4-8-3}

Before using oligonucleotides in nucleofections, the oligonucleotides (prepared as above) were incubated at 55°C for 1 hr during the assembly of the *Sp*Cas9 RNP to ensure that they were fully dissolved.

### Cell washing {#s4-8-4}

*S. rosetta* cells were first prepared for nucleofection by washing away feeder bacteria. The 120 ml culture started two days previously was homogenized by vigorous shaking and then split into 40 ml aliquots in 50 ml conical tubes. The aliquots were vigorously shaken before centrifuging the cells for 5 min at 2000 g and 22°C in a swinging bucket rotor. All but 2 ml of the supernatant, which remains cloudy with *E. pacifica* bacteria, was gently pipetted off of the pellet with a serological pipette; a fine tip transfer pipette gently removed the remaining liquid near the pellet. The three cell pellets were resuspended in artificial seawater (ASW; see [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table A) for a total volume of 50 ml, combined into one conical tube, and vigorously shaken to homogenize the cells. For a second time, the resuspended cells were centrifuged for 5 min at 2000 g and 22°C. The supernatant was removed as before, the pellet was resuspended in 50 ml of artificial seawater, and the cells were homogenized by vigorous shaking. The cells were centrifuged for a third time for 5 min at 2200 g and 22°C. After removing the supernatant as described above, the cell pellet was resuspended in 400 µl of ASW. The concentration of cells was determined by diluting 2 µl of cells into 196 µl of ASW. The diluted cells were fixed with 2 µl of 37.5% formaldehyde, vortexed, and then pipetted into a fixed chamber slide for counting with Luna-FL automated cell counter (Logos Biosystems, Anyang, KOR; Cat. No. L20001). After determining the cell concentration, the washed *S. rosetta* cells were diluted to a final concentration of 5 × 10^7^ cell/ml and split into 100 µl aliquots.

### Priming {#s4-8-5}

To prime *S. rosetta* cells for nucleofection, we treated them with a cocktail that removes the extracellular matrix as follows. Aliquots of washed cells were pelleted at 800 g and 22°C for 5 min. The supernatant was gently removed with gel-loading tips and each pellet was resuspended in 100 µl of priming buffer (40 mM HEPES-KOH, pH 7.5; 34 mM lithium citrate; 50 mM l-cysteine; 15% \[wt/vol\] PEG 8000; and 1 μM papain \[Millipore Sigma, St. Louis, MO; Cat. No. P3125-100MG\]). After incubating cells for 30--40 min, 10 µl of 50 mg/ml bovine serum albumin was added to each aliquot of primed cells to quench proteolysis from the priming buffer. Finally, the cells were centrifuged at 1250 g and 22°C for 5 min, the supernatant was removed, and the pellet was resuspended in 25 µl of SF Buffer (Lonza, Basel, Switzerland; Cat. No. V4SC-2960). The resuspended cells were stored on ice while preparing nucleofection reagents.

### Nucleofection {#s4-8-6}

Each nucleofection reaction was prepared by adding 16 µl of ice-cold SF Buffer to 4 µl of the *Sp*Cas9 RNP that was assembled as described above. (For reactions that used two different gRNAs, each gRNA was assembled with *Sp*Cas9 separately and 4 µl of each RNP solution was added to SF buffer at this step). 2 µl of the repair oligonucleotide template was added to the *Sp*Cas9 RNP diluted in SF buffer. Finally, 2 µl of primed cells were added to the solution with *Sp*Cas9 RNP and the repair template. The whole solution, which has a total volume of 24 µl (30 µl for two different *Sp*Cas9 RNPs and repair templates), was placed in one well of a 96-well nucleofection plate. The well was pulsed in a Lonza shuttle nucleofector (Lonza, Cat. No. AAF-1002B and AAM-1001S) with the CM156 pulse.

### Recovery {#s4-8-7}

Immediately after transfection, 100 µl of ice-cold recovery buffer (10 mM HEPES-KOH, pH 7.5; 0.9 M sorbitol; 8% \[wt/vol\] PEG 8000) was added to each transfection and gently mixed by firmly tapping the side of the plate or cuvette. After the cells rested in recovery buffer at room-temperature for 5 min, the whole volume of a nucleofection well was transferred to 2 ml of low nutrient media in one well of a six well plate. After 30 min, 10 µl of 10 mg/ml *E. pacifica* (prepared by resuspending a frozen 10 mg pellet of *E. pacifica* in ASW) was added to each well and the six well plate was incubated at 22°C and 60% relative humidity for downstream experiments.

Establishing clonal strains {#s4-9}
---------------------------

Here we describe how to isolate clones to establish strains. For a complete list of strains used in this study, see [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table C.

Cycloheximide selection {#s4-10}
-----------------------

One day after transfecting *S. rosetta* with *Sp*Cas9 RNPs repair oligonucleotides for *rpl36a^P56Q^* ([Figure 2](#fig2){ref-type="fig"}), 10 µl of 1 µg/ml cycloheximide was added to a 2 ml culture of transfected cells. The cells were incubated with cycloheximide for 5 days prior to genotyping and clonal isolation.

Clonal isolation {#s4-11}
----------------

To prepare cells for clonal isolation by limiting dilution, the initial cell density was determined by fixing a 200 µl sample of cells with 5 µl of 37.5% (w/v) formaldehyde and then by counting the fixed cells with a hemocytometer (Hausser Scientific, Horsham, PA; Cat. No. 1475) or Luna-FL automated cell counter. The cells were by diluted to a final concentration of 3 cells/ml in low nutrient sea water and then distributed in a 96 well plate with 100 µl/well. Thus, the mean frequency of finding a cell in each well is 0.3, which, according to a Poisson distribution, corresponds to a \> 99% probability that a given well with *S. rosetta* was founded from a single cell. Cells were grown in a 96 well plate for 5--7 days at 22°C and 60% relative humidity. Lastly, the plate was screened using phase contrast microscopy to identify wells with *S. rosetta*. Finally, larger cultures of high nutrient media were inoculated with clonal isolates to establish strains.

Genotyping by Sanger sequencing ([Figures 2](#fig2){ref-type="fig"}--[3](#fig3){ref-type="fig"} , [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) {#s4-12}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cells were harvested for genotyping by centrifuging 1 ml of cells at 4250 g and 22°C for 5 min. The supernatant was removed with a fine tip transfer pipette. (Optional: To remove lingering DNA from cells that die in the course of cycloheximide selection, the pellet was resuspended in 50 µl DNase buffer \[10 mM Tris-HCl, pH 7.6; 1 M sorbitol; 2.5 mM magnesium chloride; 0.5 mM calcium chloride; 0.1 U/µl Turbo DNase (Thermo Fisher Scientific; Cat. No. AM2238)\] and incubated at room temperature for 30 min. Afterwards, the cells were centrifuged as before, discarding the supernatant.) The cell pellet was dissolved in 100 µl of DNAzol Direct (20 mM potassium hydroxide, 60% \[w/v\] PEG 200, pH 13.3--13.5; Molecular Research Center, Inc, Cincinnati, OH; Cat. No. DN131). 5 µl of the dissolved cells were added to a 50 µl PCR reaction (Q5 DNA polymerase, NEB; see [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table B for primer sequences) and amplified with 36 rounds of thermal cycling. Samples dissolved in DNAzol direct can be directly added to PCR reactions because the pH of DNAzol Direct dramatically drops upon a ten-fold or greater dilution ([@bib19]). The PCR product was purified using magnetic beads ([@bib78]) and then submitted for Sanger sequencing (UC Berkeley DNA Sequencing facility).

Cell proliferation assays ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) {#s4-13}
-------------------------------------------------------------------------------------

We characterized the cell proliferation rates of *S. rosetta* strains by monitoring the concentration of cells over time to fit logistic growth curves and determine the doubling time. Cell proliferation assays started by diluting cultures to a concentration of 10^4^ cells/ml in high nutrient media and then distributing 0.5 ml of culture into each well of a 24 well plate. Every \~12 hr, the entire contents of one well were thoroughly homogenized by pipetting up and down and then transferred to a 1.5 ml conical tube. Three independent wells were taken for triplicate measures of cell concentration at every time point. The cells were fixed with 20 µl of 37.5% formaldehyde and mixed by vortexing. The fixed cells were stored at 4°C until the sample was used for determining the cell concentration after the full growth course.

The cell concentration was determined by counting the number of cells in a fixed-volume imaging chamber. In detail, the fixed cells were thoroughly homogenized by vortexing for 10 s and then pipetted up and down before transfer into a chamber of a Smart Slide (ibidi USA, Inc, Firchburg, WI; Cat. No. 80816) that has a fixed height of 200 µm. After allowing cells to settle to the bottom for 5 min, each chamber was imaged on an Axio Observer.Z1/7 Widefield microscope (Carl Zeiss AG, Oberkochen, Germany) and recorded with a Hamamatsu Orca-Flash 4.0 LT CMOS Digital Camera (Hamamatsu Photonics, Hamamatsu City, Japan) using either phase contrast for 10x (objective), in-focus images or a 20x brightfield image with a 1 µm overfocus to make the cells appear dark on a light gray background. The volume for each image was calculated from the image area, which was calibrated on the microscope, and the fixed height of the imaging chamber: 3.54 × 10^−4^ ml when imaged at 10x and 8.86 × 10^−5^ ml when imaged at 20x. Using automated particle detection in Fiji ([@bib90]), cells were counted in each 20x image by thresholding the image to make cells appear as black spots on a white background and then each circular spot was counted with the 'Analyze Particles' function. For early time points with fewer numbers of cells, we manually counted cells in 10x images to include more cells in a greater area for a more accurate count.

Each time course was fit by least absolute deviation curve fitting to the logistic equation:$$\text{P}_{\text{t}}\text{=}\frac{\text{K} \bullet \text{P}_{\text{0}}}{\left( {\left( {\text{K–}\text{P}_{\text{0}}} \right) \bullet \text{e}^{\text{-}\frac{\text{t}}{\text{T}}}} \right)\text{+}\text{P}_{\text{0}}},$$where *P~t~* is the cell density at time (*t*), *K* is the carrying capacity, *P~0~* is the initial cell density, and *T* is the doubling time.

Live-cell microscopy ([Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}) {#s4-14}
----------------------------------------------------------------------------------------

Glass-bottomed dishes (World Precision Instruments, Sarasota, FL; Cat. No. FD35-100) were prepared for imaging by covering the bottom with 500 µl of 0.1 mg/ml poly-D-lysine (Millipore Sigma; Cat. No. P6407-5MG) and incubating for 15 min. The poly-D-lysine was removed and then the dish was washed three times with 500 µl of ASW. Cells were placed into the dish by gently pipetting 500 µl of cells with a wide pipette tip.

Differential interference contrast (DIC) microscopy images were captured with a Zeiss Axio Observer.Z1/7 Widefield microscope with a Hamamatsu Orca-Flash 4.0 LT CMOS Digital Camera (Hamamatsu Photonics, Hamamatsu City, Japan) and 40×/NA 1.1 LD C-Apochromatic water immersion, 63×/NA1.40 Plan-Apochromatic oil immersion, or 100 × NA 1.40 Plan-Apochromatic oil immersion objectives (Zeiss).

Immunofluorescent staining and imaging ([Figure 1](#fig1){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) {#s4-15}
----------------------------------------------------------------------------------------------------------------------------------------

200 µl of *S. rosetta* cells were gently pipetted into chamber slides (ibidi; Cat. No.80826) coated with poly-D-lysine (see live cell imaging for coating procedure). Importantly, cells were pipetted using a tip that had been trimmed to create a larger bore for reducing shear forces. The cells were incubated on the coverslip for 30 min to allow the cells to adsorb to the surface.

Cells were fixed by adding 200 µl of 6% acetone in cytoskeleton buffer (10 mM MES, pH 6.1; 138 KCl, 3 mM MgCl~2~; 2 mM ethylene glycol-bis(β-aminoethylether)-*N*,*N*,*N*',*N*'-tetraacetic acid \[EGTA\]; 600 mM sucrose) and then incubated for 10 min at room temperature. After removing 200 µl from the chamber, 200 µl of 4% formaldehyde diluted in cytoskeleton buffer was added to the chamber and then incubated for 15 min at room temperature. Last, the coverslip was gently washed three times with 200 µl of cytoskeleton buffer.

Cells were permeabilized by washing the coverslip once with 200 µl of permeabilization buffer (PEM \[100 mM PIPES, pH 6.95; 2 mM EGTA; 1 mM MgCl~2~\] with 1% \[wt/vol\] bovine serum albumin (BSA)-fraction V and 0.3% \[vol/vol\] Triton X-100) and then incubated for 60 min upon a second addition of permeabilization buffer. Afterwards, 200 µl of the permeabilization buffer was replaced with primary antibodies diluted in permeabilization buffer, 1 µg/ml mouse DM1A anti-α-tubulin antibody (Thermo Fisher Scientific; Cat. No. 62204) and 1:200 rabbit anti-Rosetteless ([@bib64]). After the samples were incubated in primary antibody for 2 hr, the chamber was gently washed three times with 200 µl permeabilization buffer. Next, 200 µl of permeabilization buffer with 10 µg/ml donkey anti-mouse immunoglobulin G--AlexaFluor568 (Thermo Fisher Scientific; Cat. No. A10037), donkey anti-rabbit immunoglobulin G--AlexaFluor647 (Thermo Fisher Scientific; Cat. No. A32795), 10 μg/ml Hoechst 33342 (Thermo Fisher Scientific; Cat. No. H3570), and 4 U/ml Phalloidin-AlexaFluor488 (Thermo Fisher Scientific; Cat. No. A12379) was added to the chamber and then incubated for 40 min. Afterwards, the chamber was washed five times with PEM.

Immunostained samples were imaged on a Zeiss Axio Observer LSM 880 with an Fast Airyscan detector and a 40x/NA1.1 Plan-Apochromatic water immersion objective (Zeiss) by frame scanning in the superresolution mode with the following settings: 50 × 50 nm pixel size; 220 nm *z*-step; 0.73 μs/pixel dwell time; 750 gain; 488/561/633 nm multiple beam splitter; 633 nm laser operating at 16% power with a 570-620/645 bandpass/longpass filter; 561 nm laser operating at 16% power with a 570-620/645 bandpass/longpass filter; 488 nm laser operating at 14% power with a 420-580/495-550 bandpass filters.

Next-generation sequencing ([Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) {#s4-16}
----------------------------------------------------------------------------------------------------------------------------

We performed deep sequencing of edited cells to quantify the efficiency of genome editing ([Figure 3](#fig3){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The transfections were performed as above with the following modifications: Two transfections were conducted for each condition and combined into 1 ml of low nutrient media (see [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table A for recipe). One day after transfection, the cells were harvested and dissolved in 50 µl of DNAzol direct (Molecular Research Center, Inc). Three independent transfections performed on different days provided replicate measures for each condition ([Figure 3C](#fig3){ref-type="fig"} and [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}).

To preserve the diversity of sequences during PCR, six parallel PCR reactions (Q5 DNA polymerase, NEB) were set up with 30 µl of sample. The target locus was amplified in 15 thermal cycles, purified using magnetic beads (UC Berkeley DNA sequencing facility), and pooled together in a total volume of 180 µl. Importantly, the primers for this first round of PCR had a randomized 6-nucleotide sequence in the forward primer to distinguish PCR duplicates (primer sequences in [Supplementary file 1](#supp1){ref-type="supplementary-material"}-Table D), which allowed us to identify 4096 unique sequences. Extending this randomized sequence would result in higher sensitivity.

A second round of PCR was performed to attach adapters for Illumina sequencing. For these reactions, four replicate PCR reactions were set up with 25 µl of the purified products from the first round of PCR and primers with sequencing adapters and unique sample barcodes were attached in five thermal cycles. Afterward, the PCR products were purified using magnetic beads (UC Berkeley DNA sequencing facility) and their quality was assessed on a Bioanalyzer (UC Berkeley Functional Genomic Laboratory). The bioanalyzer traces showed that the amplicons were the proper size, yet a similar concentration of residual PCR primers remained in each sample. After quantifying DNA (Qubit; Thermo Fisher Scientific) and pooling equimolar amounts of sample, the amplicons were further purified with magnetic beads (UC Berkeley Functional Genomics Lab) and the concentration was verified using qPCR. The library was sequenced on a miSeq sequencer (Illumina, San Diego, CA) using the V3 chemistry (Illumina) for 300 rounds of paired-end sequencing, which gives up to 600 bases of sequence per sample. After sequencing the samples were separated based on their unique barcodes for further analysis of individual samples.

The editing efficiency for each sample was calculated from high-quality, unique reads. First, we used tools from the Galaxy Project ([@bib2]) to join paired-end reads into one read (fastq-join) and then retain high quality sequences (Galaxy--Filter by quality: 100% of bases with quality scores ≥ 30) with 50 bp of expected sequence from the *rosetteless* locus on the 5' and 3' ends of the amplicon (Galaxy--Cutadapt: 50 base overlap with 0.1 maximum error rate). Next, the reads were filtered for unique instances of the randomized barcode sequence from the first round PCR primers (Galaxy--Unique). We then combined matching amplicon sequences into unique bins, while counting the number of sequences in each bin (Galaxy--Collapse). The FASTA file of aligned sequences (Galaxy--ClustalW) from this initial processing was further analyzed using a custom script ([Source code 1](#scode1){ref-type="supplementary-material"}). To quantify the instances of template-mediated repair, we counted the number of sequences that had the PTS. Untemplated mutations were counted from insertions and deletions larger than 1 bp. The remaining sequences, those that were the same length as the *rosetteless* locus but did not have the exact amplicon sequence, were counted as single-nucleotide polymorphisms (SNPs). The outputs from each category were also visually inspected to reclassify incorrect calls, such as a few instances of template-directed repair in the insertions and deletion category due to mutations in the PTS. The SNP data revealed that conditions with or without the addition of *Sp*Cas9 or repair templates had same SNP frequency. Therefore, we only compared reads categorized as template-mediated repair or untemplated insertions and deletions. Importantly, this analysis may overlook some instances where DNA repair resulted in sequences that maintained the original sequence or introduced SNPs, thereby underestimating the efficiency of non-templated repair.

Statistical analyses {#s4-17}
--------------------

Differences between experimental conditions were evaluated by comparing the variance between experimental groups, each with triplicate and biologically independent measures of the response variable, with Single- or Multi-Factor Analysis of Variance (ANOVA) ([@bib113]). If the groups were very unlikely to have the same response (p\<0.05), the source of variation from Multi-Factor ANOVA was identified by performing Single-Factor ANOVA on subsets of the original experimental groups. Finally, a Tukey Multiple Comparison Test was performed after Single-Factor ANOVA showed that experimental groups were unlikely to have the same response. The specific analyses for each experiment are detailed in the following text:

[Figure 2](#fig2){ref-type="fig"}: A Two-Factor ANOVA was performed to test the effect of genotype on cell density in a serial dilution of cycloheximide, which was measured in three biological replicates. This test showed that the growth of the *rpl36a^P56Q^* strain in cycloheximide was very unlikely to be the same as the wild-type strain (p\<10^−20^).

[Figure 4](#fig4){ref-type="fig"}: Four sets of Two-Factor ANOVA tested the effect of repair template and *Sp*Cas9 cleavage on the percentage of PTS or INDEL mutations, as measured by deep sequencing of the *rosetteless* surrounding the position supercontig 8: 429,354 nt in three biological replicates of each condition. In the first and second sets of Two-Factor ANOVA, the outcomes of PTS mutations were separately analyzed from INDEL mutations, and within each set, we tested the effect of adding *Sp*Cas9 and repair templates on the mutation frequency, which showed that the frequencies of PTS or INDEL mutations were very unlikely to be the same in the presence of *Sp*Cas9 versus its absence (p\<10^−15^ for PTS mutations and p\<0.02 for INDEL mutations). In the third and fourth sets of Two-Factor ANOVA, the editing outcomes in the absence of *Sp*Cas9 were separately analyzed from the outcomes in the presence of *Sp*Cas9 as we tested the effects of mutation type (PTS versus INDEL) and the addition of repair templates on the mutation frequency. Importantly, the editing outcomes in the absence of *Sp*Cas9 were the same across all conditions (p\<0.34), indicating that there is virtually no mutagenesis in the absence of *Sp*Cas9. Furthermore, in the presence of *Sp*Cas9, the editing outcomes across all repair templates were very improbably the same (p\<10^−15^). A follow-up, Single-Factor ANOVA that tested the effect of adding repair templates on the frequency of INDEL mutations in the presence of *Sp*Cas9 showed no differences between repair template groups (p\<0.60). Whereas, the same analysis for PTS mutations in the presence of *Sp*Cas9 showed that editing frequencies were very unlikely to be the same (p\<10^−4^) across different repair templates. Therefore, multiple comparisons with the Tukey method were performed on all of the pairwise combinations of the repair template groups in the presence of *Sp*Cas9. These multiple comparisons showed that none of the repair templates resulted in the same frequency of PTS mutations. For example, the comparison that was most likely to have the same repair outcome was the single-stranded, sense oligonucleotide versus the duplex repair template (p\<0.04); whereas, all other comparisons between repair templates were much less likely to be the same (0.0001 \< p \< 0.004). Among these repair templates, the single-stranded, sense oligonucleotide resulted in the highest average frequency of PTS mutations (1.57%).

[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}: After finding that both genotype and RIF induction affected the percentage of cells in rosettes with a Two-Factor ANOVA, in which three biological replicates were used for each group, a Single-Factor ANOVA followed by a Tukey Multiple Comparison Test was performed on groups that had been induced with RIFs to test the effect of genotype on rosette development. These tests showed that wild-type and *rpl36^P56Q^* strains were similarly induced (p\<0.84), which was also the case for *rtls^PTS1^ rpl36^P56Q^* and *rtls^tl1^* (p\<0.99), and rosette development was very unlikely to be the same between wild-type or *rpl36^P56Q^* strains versus *rtls^PTS1^ rpl36^P56Q^* or *rtls^tl1^* strains (p\<10^−10^). Note that such tests were not performed for the uninduced samples because the fraction of cells in rosettes was zero for all three measurements of each genotype.

[Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}: The effect of genotype on growth rate was tested with a SIngle-Factor ANOVA using three biological replicate measures of the doubling time (*T*) for each strain, which showed that the doubling-times were probably the same among all strains (p\<0.08).

[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}: The outcomes of PTS mutations were separately analyzed from INDEL mutations in two sets of Single-Factor ANOVA to test the effect of repair template in the presence of SpCas9 on mutation frequency. The frequency of INDEL mutations was most likely the same between all repair templates (p\<0.17). In contrast, the frequency of PTS mutations was improbably the same between repair templates (p\<10^−6^), yet multiple comparisons with the Tukey test showed that there was no difference between the duplex templates (0.50 \< p \< 0.99) just as there were no differences between the single-stranded templates with truncated homology arms (0.99 \< p \< 1.00). Thus, the major effect on PTS mutation frequency was between the duplex templates versus the single-stranded, truncated templates (p\<0.02).
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BASH script for quantifying the frequency of repair outcomes from deep sequencing data that were preprocessed and aligned in a Galaxy server ([@bib2]).

###### Tables of critical resources.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"Genome editing enables reverse genetics of multicellular development in the choanoflagellate *Salpingoeca rosetta*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Alejandro Sánchez Alvarado as the Reviewing Editor and Patricia Wittkopp as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Margaret A Titus (Reviewer \#1); Iñaki Ruiz-Trillo (Reviewer \#2); Matthew C Gibson (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as *eLife* papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.

Summary:

This work represents an important step forward for the study of choanoflagellates. It reports the first evidence of a reverse genetics approach based on CRISPR/Cas-9 mediated genome editing in *Salpingoeca rosetta*, an emerging model to study the origin and evolution of animal multicellularity. In this work, authors engineered a cycloheximide-resistance selectable marker to demonstrate genome editing and to enrich for edited cells. Later they disrupted *rosetteless*, an *S. rosetta* C-type lectin gene essential for rosette colonies development, the absence of which impairs the formation of rosette colonies. This work represents an important advance to investigate in vivo the function of genes using a genome editing-based approach in *S. rosetta*, which will greatly expand its value as an experimental model to address animal origins.

Essential revisions:

1\) The authors point out that the method here could also be used to edit the genome of related choanoflagellates. This would assume that the transfection method would work as well on these (or some of them) as well as it does for *S. rosetta*. Has this been tested or is there a strong reason to think that this will be the case, especially for the more divergent members of the species?

2\) One desired use of gene editing would be to introduce a tag to a gene of interest for expression of an in-frame fusion at endogenous levels. The insertions made are rather small in size. Have the authors tried to fuse a GFP, for example, to a gene of interest and found this to work? Or do the data the authors have in hand support the possibility to insert a larger DNA to generate such a fusion?

3\) One consideration with gene editing is the introduction of off-target mutations. Do the authors have any information about the possibility of generating additional, background mutations in the genome when using the co-CRISPR approach?

4\) One nagging question in CRISPR/Cas9 reverse genetic approaches is the possibility of off-target mutagenesis, which is most effectively ruled out by 1)independent gRNAs; 2) evidence for Mendelian segregation and 3) non-complementation between independent alleles in a diploid organism. All experiments shown here are performed in haploid cells. However, *Salpingoeca rosetta* can undergo sexual reproduction through a diploid state (Levin and King, 2013) with genetic analysis suggesting that inheritance patterns follow Mendel\'s law of segregation and independent assortment (Levin et al., 2014). Can CRISPR/Cas9 mutagenized choanoflagellates undergo sexual reproduction? If so, is allele frequency in line with the rules of classical Mendelian genetics? How could this be utilized in future experiments to improve genetic resolution? A discussion of this information, if possible, would help to fully expand on the potential uses for targeted mutagenesis in *S. rosetta*.

5\) In the manuscript version for review, the protocol availability on protocol.io appears only once -- towards the middle of the Materials and methods (subsection "Delivery of gene editing cargoes with nucleofection"). I would suggest this information additionally be listed in the Abstract and/or somewhere in the main body of the paper.

6\) By directly showing the loss of *Rosettless* protein in the mutants, Supplementary Figure 3C offers striking visual corroboration of the genetic and genomic evidence of targeted mutagenesis. I found this to be particularly strong data and would suggest moving these panels to the main text. Within the figures, it would also be helpful to readers to clearly indicate the color key for the markers used somewhere in the figure itself (*Rosetteless* (green), α-tubulin (gray), and actin (magenta).

7\) The main Figure 1 is essentially review information and the main Figure 2 is important but graphically and conceptually quite simple. The authors should consider fusing these figures by putting Figure 1 in a horizontal format with the Figure 2 panels below. I think this would be more engaging for readers and also open up room to move Supplementary Figure 3 wholesale into the main presentation.

8\) The authors provide detailed analysis to show that the inclusion of a donor template significantly favors DNA repair over indel creation (Figure 4, Figure 4---figure supplement 1). However, there appears to be no significant difference in editing outcomes with different types of repair templates as long as the template has both left and right homology arms. Maybe I\'m missing something, but this seems at odds with the final sentence of the Results section.

10.7554/eLife.56193.sa2

Author response

> Essential revisions:
>
> 1\) The authors point out that the method here could also be used to edit the genome of related choanoflagellates. This would assume that the transfection method would work as well on these (or some of them) as well as it does for *S. rosetta*. Has this been tested or is there a strong reason to think that this will be the case, especially for the more divergent members of the species?

This point highlights that a limiting step for performing genome editing and reverse genetics in *S. rosetta* and other choanoflagellates has been the establishment of an efficient method for transfection. In our previous paper that focused on transfecting *S. rosetta* (Booth et al., 2018), we described how transfection could be applied to other systems. In this paper, we raise the possibility of establishing genome editing in other choanoflagellates (Discussion) as a hypothetical ("...we anticipate...") based on lessons that we've learned from *S. rosetta*.

In fact, we have helped advise another group that has adapted the transfection procedure from *S. rosetta* to successfully transfect another choanoflagellate species. As these data are still unpublished and not ours to report, we think it is most appropriate to simply raise the possibility that our methods might extend to other choanoflagellates.

> 2\) One desired use of gene editing would be to introduce a tag to a gene of interest for expression of an in-frame fusion at endogenous levels. The insertions made are rather small in size. Have the authors tried to fuse a GFP, for example, to a gene of interest and found this to work? Or do the data the authors have in hand support the possibility to insert a larger DNA to generate such a fusion?

We agree that one of the desired uses for gene editing is the insertion of fluorescent protein tags at endogenous loci. Although we do not currently have data that demonstrate the incorporation of such tags, we are actively pursuing these experiments (when we can return to lab, that is). It is worth noting that even in large research communities, such as researchers using human cell lines and/or established model organisms, there has often been a long wait between establishing genome editing and inserting large tags (Hsu et al., 2014) with more and more clever insights continually being published (e.g. Li et al., 2019). Nonetheless, with the tools in hand, we are optimistic that small epitope tags could be incorporated at endogenous loci to accelerate protein localization experiments. As we have not yet been able to pursue those experiments, we have not commented on that particular use in the submitted manuscript.

> 3\) One consideration with gene editing is the introduction of off-target mutations. Do the authors have any information about the possibility of generating additional, background mutations in the genome when using the co-CRISPR approach?

We agree that an important concern for any CRISPR-based approach is the possibility of introducing off-target mutations. In fact, this potential problem was a key motivation behind our decision to perform genome editing with the *Sp*Cas9 RNP (as opposed to a *cas9* plasmid), as previous studies comparing off-target mutations with different Cas9-delivery methods showed fewer off-target mutations with the Cas9 RNP (Kim et al., 2014; Liang et al., 2015; Han et al., 2020). We have now added this point and associated references to our list of reasons for using the *Sp*Cas9 RNP:

"We favored delivering the *Sp*Cas9 RNP rather than expressing *Sp*Cas9 and gRNAs from plasmids, as RNA polymerase III promoters for driving gRNA expression have not yet been characterized in *S. rosetta* and the overexpression of *Sp*Cas9 from plasmids can be cytotoxic for other organisms (Jacobs et al., 2014; Jiang et al., 2014; Shin et al., 2016; Foster et al., 2018) as well as increase the likelihood of introducing off-target mutations (Kim et al., 2014; Liang et al., 2015; Han et al., 2020)."

Although we did not directly measure the frequency of off-target mutagenesis during genome editing in *S. rosetta*, genetic crosses have been performed in *S. rosetta* (Levin et al., 2014; Wetzel et al., 2018) and offer a means to eliminate background mutations for future studies (also see our response to comment 4). Moreover, circumstantial evidence suggests that off-target mutagenesis may be infrequent in *S. rosetta.* Off-target mutagenesis in other organisms typically occurs through untemplated insertions and/or deletions (Kim et al., 2014; Liang et al., 2015; Han et al., 2020), but these are rare according to our next generation sequencing at the *rosetteless* locus (Figure 4).

> 4\) One nagging question in CRISPR/Cas9 reverse genetic approaches is the possibility of off-target mutagenesis, which is most effectively ruled out by 1)independent gRNAs; 2) evidence for Mendelian segregation and 3) non-complementation between independent alleles in a diploid organism. All experiments shown here are performed in haploid cells. However, Salpingoeca rosetta can undergo sexual reproduction through a diploid state (Levin and King, 2013) with genetic analysis suggesting that inheritance patterns follow Mendel\'s law of segregation and independent assortment (Levin et al., 2014). Can CRISPR/Cas9 mutagenized choanoflagellates undergo sexual reproduction? If so, is allele frequency in line with the rules of classical Mendelian genetics? How could this be utilized in future experiments to improve genetic resolution? A discussion of this information, if possible, would help to fully expand on the potential uses for targeted mutagenesis in *S. rosetta*.

Thank you for encouraging us to include these points for discussion. Based on this comment, we have added the following paragraph to the Discussion to better highlight how independent alleles can work together to establish genotype to phenotype relationships, just as we show in this manuscript with two *rosetteless* alleles (Figure 3). We also highlight how genetic crosses and transgenesis could further aid reverse genetics.

"Moving forward, the approach established here promises to accelerate future research on choanoflagellates. \[...\] Tools that have been previously used in forward genetic approaches, such as genetic crosses (Levin and King, 2013; Levin et al., 2014; Woznica et al., 2017) and stable transgenesis (Wetzel et al., 2018), may also provide the means to rapidly generate strains with different genetic backgrounds to complement mutants, to reveal epistasis, or simply to eliminate off-target mutations that may arise during genome editing."

To respond to the specific question about whether genome edited strains can mate, we do expect that genome edited strains can undergo sexual reproduction, and we have some preliminary evidence, but we feel this goes beyond the scope of the current study and the relevant data do not yet meet our standards for publication. As previous forward genetic studies have shown, the frequency of alleles in haploid progeny from genetic crosses do obey classical Mendelian genetics. Except for tightly linked loci and potential epistasis between alleles, we would expect that these results should be generalizable to genome edited strains.

> 5\) In the manuscript version for review, the protocol availability on protocol.io appears only once -- towards the middle of the Materials and methods (subsection "Delivery of gene editing cargoes with nucleofection"). I would suggest this information additionally be listed in the Abstract and/or somewhere in the main body of the paper.

Thank you for this suggestion. We have added a mention of the protocol in the Introduction:

"Here we report a reliable method for genome editing to perform reverse genetics in *S. rosetta* that we have developed into a publicly-accessible protocol (https://dx.doi.org/10.17504/protocols.io.89fhz3n)."

> 6\) By directly showing the loss of Rosettless protein in the mutants, Supplementary Figure 3C offers striking visual corroboration of the genetic and genomic evidence of targeted mutagenesis. I found this to be particularly strong data and would suggest moving these panels to the main text. Within the figures, it would also be helpful to readers to clearly indicate the color key for the markers used somewhere in the figure itself ( Rosetteless (green), α-tubulin (gray), and actin (magenta).

Done.

> 7\) The main Figure 1 is essentially review information and the main Figure 2 is important but graphically and conceptually quite simple. The authors should consider fusing these figures by putting Figure 1 in a horizontal format with the Figure 2 panels below. I think this would be more engaging for readers and also open up room to move Supplementary Figure 3 wholesale into the main presentation.

Thank you for these suggestions. Following these recommendations, we have moved the immunofluorescence images from the supplement to the main text Figure 3G-J. Although simple, we think Figures 1 and 2 make distinct points for readers to take away and would like to keep them as separate figures.

> 8\) The authors provide detailed analysis to show that the inclusion of a donor template significantly favors DNA repair over indel creation (Figure 4, Figure 4---figure supplement 1). However, there appears to be no significant difference in editing outcomes with different types of repair templates as long as the template has both left and right homology arms. Maybe I\'m missing something, but this seems at odds with the final sentence of the Results section.

Thank you for this question, as it emphasizes that we need to clarify our data regarding relative rates of repair with different templates. Although the frequencies of genome editing appear largely comparable among the repair templates (Figure 4C; subsection "*S. rosetta* preferentially introduces genome-edited mutations from DNA templates"), there are meaningful differences that may be relevant for experimental design. In Figure 4C, it may have been difficult to discern those differences because the logarithmic y-axis compresses values and deemphasizes the variance and differences between experiments with different repair templates, so we have revised this panel to extend the y-axis. We have also underscored the differences between each repair template by reporting in the text the P-values from ANOVA and multiple comparison tests. To the reviewers' point, we also emphasize in the main text that the editing frequencies are similar for all practical purposes.

"We found that the *S. rosetta* genome could be edited in a *Sp*Cas9-dependent manner using a variety of templates (Figure 4C, Figure 4---figure supplement 1C). In the presence of the *Sp*Cas9, INDEL mutations occurred at a frequency of \< 0.1%, either in the presence or absence of DNA repair templates (Figure 4C, Figure 4---figure supplement 1D-E). In contrast, the addition of *Sp*Cas9 with DNA repair templates that encoded the PTS resulted in PTS mutations at a frequency of 0.79-1.57%, which is at a ten-fold higher frequency than the INDEL mutational frequency (Two-Factor ANOVA: *P* \< 10^-13^). Notably, the total frequency of genome editing (\~ 1%) is on the same order of magnitude as transfection efficiency (\~1%; Booth et al., 2018), suggesting that the delivery of *Sp*Cas9 and repair templates is the biggest factor limiting genome editing efficiency.

In the absence of *Sp*Cas9, we observed two types of *Sp*Cas9-independent genome edits. The first was a single INDEL mutation detected in a population of cells transfected with the antisense repair template, and the second was the detection of PTS mutations at an average frequency of \~ 0.02% upon the delivery of a double-stranded repair template. Although the frequency of these mutations occurred at a rate less than or equal to the detection threshold (\~ 0.02%), meaning that we could not confidently conclude that differences exist between any of the samples (Two-Factor, ANOVA: *P* \< 0.27), the presence of these mutations is consistent with a low frequency of endogenous DNA repair. These results also emphasize that the addition of *Sp*Cas9 was essential for efficient, targeted mutagenesis (Two-Factor ANOVA: *P* \< 0.02 for INDEL mutations and *P* \< 10^-13^ for PTS mutations).

Altogether, our optimization efforts revealed that the delivery of the *Sp*Cas9 with a DNA template spanning both sides of the *Sp*Cas9 cleavage site introduced PTS mutations at a frequency of \~ 1%. We recommend using a sense-oriented, single-stranded template for genome editing, as this template led to the highest frequency of PTS mutations (Single-Factor ANOVA, Tukey Multiple Comparison Test: *P \< 0.04*) and costs less to synthesize than a double-stranded template."

We also point out other considerations that have led us to favor the sense repair template. First, single-stranded oligonucleotides for the sizes of repair templates that were used in this paper are cheaper and faster to obtain compared to duplex templates. Second, the single-stranded oligo in the sense direction leads to higher editing frequencies (Figure 4 and Figure 2---figure supplement 2E, compare templates with 20-30 base homology arms). Given these collective considerations, we argue that the single-stranded, sense template represents the all-around best guide template to be used by other researchers who wish to implement these methods for their own research.

[^1]: Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States.
